scispace - formally typeset
H

Hiroshi Maeda

Researcher at Kumamoto University

Publications -  915
Citations -  67944

Hiroshi Maeda is an academic researcher from Kumamoto University. The author has contributed to research in topics: Neocarzinostatin & Nitric oxide. The author has an hindex of 103, co-authored 893 publications receiving 63370 citations. Previous affiliations of Hiroshi Maeda include Osaka University & Okayama University.

Papers
More filters
Journal ArticleDOI

Enhancement by verapamil of neocarzinostatin action on multidrug-resistant Chinese hamster ovary cells: possible release of nonprotein chromophore in cells.

TL;DR: Findings favor the possibility that NPC was excreted via P‐glycoprotein, which may contribute to the resistance of CHRC5 cells to NCS.
Patent

Method for detecting ground fault in ac-side connection wire of rectifier for dc feeding

TL;DR: In this article, the authors proposed a method for detecting a ground fault in an AC-side connection wire of a rectifier for DC feeding by measuring a current flowing in a ground wire 10 with which a shield layer 9s of a connection wire was installed between a transformer 7 for the rectifier and a Rectifier 8 at a substation 2 for DC electric trains.
Journal ArticleDOI

Microstructures and superconducting properties of V doped Bi2223 tapes

TL;DR: In this paper, the powder-in-tube method was used to prepare Ag-sheathed tapes by using V doped Bi2223 powder, which greatly enhances the phase formation of the tapes without any degradation of the superconducting critical temperature Tc.
Journal Article

Cytotoxicity of smancs in comparison with other anticancer agents against various cells in culture.

TL;DR: Results clearly indicate that smancs is an unique antitumor agent with a broad antitumors spectrum which exhibits some characteristics similar to, but also some very different from NCS.
Journal ArticleDOI

On the tryptophan content of neocarzinostatin.

TL;DR: Two tryptophan residues were determined in the polypeptide antitumor antibiotic neocarzinostatin using 2-hydroxy-5-nitrobenzyl bromide and 2-nitrophenyl-sulfenyl chloride in 50 % acetic acid.